CytRx cancer drug shows promise in mid-stage study
January 08, 2015 at 09:33 AM EST
Jan 8 (Reuters) - CytRx Corp said its cancer drug was effective against a type of skin cancer in HIV+ patients, sending its shares up 13 percent before the bell.
